Search results

Skip to results

Type

Status

Last updated

Showing 1 result for tirofiban

  1. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (TA47)

    Evidence-based recommendations on glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban) for treating acute coronary syndromes in adults.

    Technology appraisal guidance
    Last updated
    1 March 2010
    View recommendations

    Sections for TA47